NUVL FY 2023 Earnings — Nuvalent, Inc. Revenue & Financial Results | Market Cap Arena

NUVLNuvalent, Inc.

$8B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$149M

Net Income

-$126M

EPS (Diluted)

$-2.17

Cash Flow

Operating Cash Flow

-$100M

Free Cash Flow

-$100M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$732M

Total Liabilities

$32M

Stockholders' Equity

$701M

Cash & Equivalents

$335M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$149M	-$86M	-73.6%
Net Income	-$126M	-$82M	-54.2%